Last updated on July 2019

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis


Brief description of study

The purpose of the study is to demonstrate the efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared to placebo in the treatment of subjects with active nonradiographic axial spondyloarthritis (nr-axSpA).

Clinical Study Identifier: NCT03928704

Find a site near you

Start Over

As0010 50060

Upland, CA United States
  Connect »

As0010 50015

Hagerstown, MD United States
  Connect »

As0010 50016

Saint Louis, MO United States
  Connect »

As0010 50020

Duncansville, PA United States
  Connect »

As0010 50054

Oklahoma City, OK United States
  Connect »

As0010 50001

Jackson, TN United States
  Connect »

As0010 50012

Memphis, TN United States
  Connect »

As0010 40032

Debrecen, Hungary
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.